Astellas Pharma reported JPY263.91B in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Astellas Pharma 4503:JP Y 263912M 13618M
Chugai Pharma 4519:JP Y 153353M 39874M
Daiichi Sankyo 4568:JP Y 178917M 37069M
Eisai 4523:JP Y 159644M 53183M
Kyowa Hakko Kirin 4151:JP Y 65050M 6327M
M3 2413:JP 28.3B 741M
Otsuka Holdings 4578:JP Y 256792M 29975M
Shionogi 4507:JP Y 56634M 452M
Sumitomo Dainippon 4506:JP Y 92720M 4508M
Terumo 4543:JP Y 94259M 8904M